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SUMMARY 24 
 25 
The Campylobacter jejuni capsular polysaccharide is important for virulence and often 26 
contains a modified heptose. In strain ATCC 700819 (a.k.a. NCTC 11168), the modified 27 
heptose branches off from the capsular backbone and is directly exposed to the 28 
environment. We reported previously that the enzymes encoded by wcaG, mlghB, and 29 
mlghC are involved in heptose modification. Here, we show that inactivation of any of 30 
these genes leads to pr duction of capsule lacking modified heptose and alters the 31 
transcription of other capsule modification genes differentially. Inactivation of mlghB or 32 
mlghC, but not of wcaG, decreased susceptibility to bile salts and abrogated invasion of 33 
intestinal cells. All mutants showed increased sensitivity to serum killing, especially 34 
wcaG::cat, and had defects in colonization and persistence in chicken intestine, but did 35 
not show significant differences in adhesion, phagocytosis, and intracellular survival in 36 
murine macrophages. Together, our findings suggest that the capsular heptose 37 
modification pathway contributes to bacterial resistance against gastrointestinal host 38 
defenses and supports bacterial persistence via its role in serum resistance and invasion of 39 
intestinal cells. Our data further suggest a dynamic regulation of expression of this 40 
pathway in the gastrointestinal tract. 41 
 42 
43 
Page 2 of 74Molecular Microbiology
For Peer Review
 
 3
INTRODUCTION 44 
Campylobacter jejuni infections are the leading cause of enteritis worldwide (Rautelin 45 
and Hanninen, 2000; Wassenaar and Blaser, 1999).  Infected patients can also develop 46 
neurological complications such as Guillain-Barre and Miller-Fischer syndromes 47 
(Godschalk et al., 2004; Godschalk et al., 2007). Numerous factors contribute to 48 
pathogenicity of C. jejuni and successful host colonization, including production of toxins 49 
and glycoproteins (Guerry et al., 2006; Kakuda and DiRita, 2006; Karlyshev et al., 2004; 50 
Szymanski et al., 2002; Vijayakumar et al., 2006) and resistance to bile salts (Lin et al., 51 
2003; Lin et al., 2005). Flagella-mediated motility also contributes to the virulence of C. 52 
jejuni (Biswas et al., 2007), as it facilitates colonization of the mucus layer covering the 53 
intestinal epithelium (Beery et al., 1988; Lee et al., 1986) and subsequent invasion of 54 
epithelial cells (Jin et al., 2001; Konkel et al., 2005; Pei and Blaser, 1993; Vijayakumar 55 
et al., 2006). Survival of C. jejuni within macrophages for several days is also a key 56 
virulence factor (Day et al., 2000; Kiehlbauch et al., 1985), and epithelial and 57 
macrophage cell damage resulting from invasion may be critical for the inflammatory 58 
response elicited by C. jejuni infection (Biswas et al., 2000; Fauchere et al., 1986; 59 
Manninen et al., 1982; Newell and Pearson, 1984; Newell et al., 1985; Szymanski et al., 60 
1995). Further, the surface expression of lipooligosaccharide (LOS), which in many C. 61 
jejuni strains mimics human gangliosides, has been associated with autoimmune reactions 62 
implicated in the Guillain-Barre and Miller-Fischer syndromes (Godschalk et al., 2007; 63 
Mishu and Blaser, 1993; Salloway et al., 1996; Yuki et al., 1994). 64 
C. jejuni also produces a surface capsular polysaccharide (CPS) (Karlyshev et al., 65 
2000; Karlyshev et al., 2001) initially identified as a heat-stable antigen and thought to be 66 
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a lipopolysaccharide (Preston and Penner, 1989). Mutational studies have demonstrated 67 
that CPS is a virulence factor for C. jejuni. For example, a non-capsular kpsE mutant of 68 
strain ATCC 81116 shows reduced adherence and invasion of intestinal epithelial cells 69 
(Bachtiar et al., 2007), and a non-capsular kpsM mutant of strain ATCC 81-176 has 70 
reduced invasion of intestinal epithelial cells, is attenuated in a ferret model (Bacon et al., 71 
2001), and has decreased ability to colonize the gut in chickens (Jones et al., 2004). Non-72 
capsular mutants of invasive clinical isolates 84-25 and 84-19 are also more readily killed 73 
by serum complement than wild type (Keo et al., 2011).  74 
The CPS from strain ATCC 700819 (a.k.a. NCTC 11168) used in this study 75 
consists of a phospholipid anchor (Corcoran et al., 2006) and repeating units containing a 76 
backbone of β-D-ribofuranose (β-D-Ribf), 2-acetamido-2-deoxy-β-D-galactofuranose (β-77 
D-GalfNAc), and α-D-glucopyranuronic acid (α-D-GlcpA)  amidated with 2-amino-2-78 
deoxyglycerol (GroN) or ethanolamine (EtN) (Fig. 1A). The repeating units also 79 
comprise a side branch consisting of a modified heptose: 6-O-methyl-D-glycero-α-L-80 
gluco-heptopyranose (6-O-Me-D-α-L-glucoHepp) (McNally et al., 2007; St Michael et 81 
al., 2002; Szymanski et al., 2003) or 3,6-O-Me2-D-α-L-glucoHepp (McNally et al., 2007). 82 
Addition of O-methyl phosphoramidate (MeOPN) moieties onto heptose and GalfNAc 83 
residues has also been reported (McNally et al., 2007; Szymanski et al., 2003). The role 84 
of MeOPN modification of CPS in virulence and host colonization is controversial. A 85 
contribution to insecticidal activity was demonstrated in one study (Champion et al., 86 
2010), but another study showed neither insecticidal activity nor any effect on chicken 87 
colonization (van Alphen et al., 2014). The MeOPN modification may increase invasion 88 
to epithelial cells and resistance to serum killing (van Alphen et al., 2014) or modulate 89 
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host immune responses (Maue et al., 2013). The contribution to virulence of the uniquely 90 
modified heptoses remains unknown. Due to their branch location in the CPS of strain 91 
ATCC 700819, the modified heptose residues protrude into the extracellular 92 
environment, becoming the outermost exposed carbohydrates of the CPS.  93 
Various heptose derivatives are found in the CPS of C. jejuni (Aspinall et al., 94 
1992; Aspinall et al., 1995a; Chen et al., 2008; Kilcoyne et al., 2006), C. coli (Aspinall et 95 
al., 1993) and Burkholderia pseudomallei (Perry et al., 1995; Reckseidler et al., 2001), in 96 
the exopolysaccharide of C. lari (Aspinall et al., 1995b), and in the lipopolysaccharide of 97 
Yersinia pseudotuberculosis (Samuelsson et al., 1974). We previously demonstrated that 98 
the modified heptoses play a role in Y. pseudotuberculosis virulence (Ho et al., 2008; 99 
Kondakova et al., 2008). Variations in the heptose structure (ring configuration and 100 
modifications) among different isolates and species suggest specific adaptations of the 101 
heptose residue to its function within the polysaccharide. We therefore hypothesized that 102 
the modified heptoses and their unusual ring configurations are important to fine tune 103 
host-bacteria interactions. 104 
Genomic sequence data of strain ATCC 700819 suggest that the C. jejuni CPS is 105 
related to group II and group III CPS of other Gram-negative bacteria (Karlyshev et al., 106 
2000). CPS gene clusters of E. coli strains that produce type II and III CPS show a 107 
conserved organization of the genes into three regions (Boulnois et al., 1987; Boulnois 108 
and Roberts, 1990). Regions 1 and 3 include genes involved in CPS export, such as the 109 
gene for the CPS ABC-transporter component KpsM for transport across the inner 110 
membrane (Cuthbertson et al., 2010; Whitfield, 2006). The central region 2 comprises 111 
genes for the synthesis of serotype-specific sugars and their assembly into repeating units 112 
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(Roberts et al., 1988a; Roberts et al., 1988b). These features apply to C. jejuni strain 113 
ATCC 700819 (Fig. 1B). In the CPS cluster of this strain and also in B. pseudomallei, 114 
region 2 contains genes devoted to the synthesis of GDP-D-glycero-α-D-manno-heptose 115 
(Kneidinger et al., 2001; Parkhill et al., 2000; Reckseidler et al., 2001), suggesting that 116 
this compound is likely the precursor for the synthesis of the modified heptose present in 117 
their CPS, as demonstrated previously for the 6-deoxy-D-manno-heptose in Y. 118 
pseudotuberculosis (Butty et al., 2009). 119 
 We recently elucidated the biochemical synthesis pathways of the 6-deoxy-D-120 
altro-heptose present in C. jejuni 81-176, which involved the sequential activity of the 121 
C4, C6 dehydratase DdahA (a.k.a. WcbK), a C3 epimerase DdahB (a.k.a. Cjj1430) and a 122 
C4 reductase DdahC (a.k.a. Cjj1427) on GDP-D-glycero-D-manno-heptose (McCallum et 123 
al., 2011; McCallum et al., 2012). This pathway is under post-translational regulation by 124 
the activity of WcaG, a C4 reductase encoded by the CPS cluster itself that reduces the 125 
DdahA product, thereby diverting it off the altro-heptose synthesis pathway. We also 126 
showed additional regulation of the biosynthesis pathway via interactions between WcaG 127 
and DdahC. Using this knowledge, we demonstrated the C3, C5 epimerase activity of 128 
MlghB (encoded by mlghB, a.k.a. cj1430c) and the C4 reductase activity of MlghC 129 
(encoded by mlghC, a.k.a. cj1428c) of C. jejuni ATCC 700819 (Fig 1B) (McCallum et 130 
al., 2013). This was achieved by using a hybrid pathway that combined MlghB and 131 
MlghC from C. jejuni ATCC 700819 with the DdahA dehydratase from C. jejuni 81-176 132 
(Fig 2) since the putative oxidase MlghA necessary to initiate the pathway in C. jejuni 133 
ATCC 700819 is unknown. We also showed a C4 reductase activity on the DdahA 134 
product for the WcaG enzyme encoded by wcaG (a.k.a. cj1427c) in strain ATCC 700819 135 
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(McCallum et al., 2013). The proposed 6-O-methyl-D-glycero-α-L-gluco-heptose (called 136 
thereafter 6OMe-Hep) synthesis pathway is depicted in Fig. 2. Our biochemical work 137 
suggests that WcaG, MlghB, and MglhC are required for CPS heptose modification. This 138 
agrees with data showing that homologues of wcaG, mlghB, and mlghC are only found in 139 
CPS biosynthesis loci of strains whose CPS contains modified heptoses (Karlyshev et al., 140 
2005; St Michael et al., 2002), and with the observation that inactivation of mlghC results 141 
in loss of the modified heptose (St Michael et al., 2002).  142 
In this study, we investigated the role of wcaG, mlghB, and mlghC genes from 143 
strain ATCC 700819 in CPS synthesis and function. Using a panel of defined mutants, 144 
we determined the contribution of each gene to CPS composition and to phenotypes 145 
associated with pathogenesis including protection against bile salts, detergents and serum, 146 
and bacterial motility. We also tested the contribution of these genes to C. jejuni’s 147 
adhesion and invasion of intestinal epithelial cells, survival within macrophages, and 148 
colonization of the chicken intestine. Our results demonstrate that wcaG, mlghB, and 149 
mlghC are required for CPS heptose modification and indicate that the modified heptoses 150 
contribute to the pathogenicity of C. jejuni ATCC 700819. 151 
 152 
RESULTS 153 
Genetic characterization of the capsular heptose biosynthesis mutants 154 
 155 
Insertional mutants in wcaG, mlghB, mlghC, and kpsM genes were constructed as 156 
described under Experimental Procedures. PCR and Southern blot analyses indicated that 157 
each mutant contained the disrupted targeted gene without compromising the surrounding 158 
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genes (data not shown). One of the wcaG::cat mutants, named wcaG::cat∆, also had a 159 
6.1-kb deletion removing genes cj1421c to cj1426c. This mutant was included in our 160 
studies for the following reasons. First, the deletion removes cj1425c-cj1423c, which are 161 
involved in the synthesis of the heptose precursor (GDP-glycero-manno-heptose, Fig.1B) 162 
(Karlyshev et al., 2005; Kneidinger et al., 2001; Parkhill et al., 2000; Valvano et al., 163 
2002), suggesting that wcaG::cat∆ should lack heptose in its CPS. Second, the deletion 164 
also eliminates the putative heptose methyltransferase cj1426c (Fig.1B) (Sternberg et al., 165 
2013), thereby ensuring lack of methylation. Third, cj1422c and cj1421c, which are also 166 
deleted, encode enzymes for the transfer of MeOPN to D-α-L-glucoHepp and β-D-167 
GalfNAc, respectively (Fig.1B) (Karlyshev et al., 2005; McNally et al., 2007). While 168 
MeOPN synthesis genes (cj1415c-cj1418c) are intact, the attachment of MeOPN to the 169 
CPS should not occur in this mutant. The efore, wcaG::cat∆ should produce a CPS 170 
backbone devoid of modifications (no heptose, no methylation and no MeOPN), thereby 171 
serving as a valuable control in our study. The kpsM mutant provided a non-capsular, 172 
negative control since KpsM is a critical component of the ABC transporter for CPS 173 
export across the cytoplasmic membrane (Silver et al., 2001). Complemented strains 174 
were constructed by re-introducing the original genes in the chromosome between the 175 
16S and 23S rRNA genes and using the constitutive OmpE promoter as described 176 
previously (Karlyshev and Wren, 2005). 177 
For all phenotypic analyses, the strains were revived under appropriate antibiotic 178 
selection, but the final sub-culture prior to phenotypic analysis was performed in the 179 
absence of antibiotic selection so that all strains were grown under the exact same 180 
conditions. Bacteria were harvested and suspensions normalized to the same OD600nm to 181 
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alleviate potential variation arising from different growth rates. CFU measurements 182 
performed on bacterial suspensions used as inoculum for phenotypic assays indicated 183 
similar viability of all strains used as measured after 24 h of growth (data not shown). 184 
 185 
Mutants in the heptose modification pathway produce high molecular weight CPS 186 
 187 
The effect of inactivation of heptose modification genes on CPS synthesis was 188 
investigated by SDS-PAGE and silver staining of CPS obtained by hot water/phenol 189 
extraction (Westphal and Jann, 1965) and ultracentrifugation. The wild type had high and 190 
low molecular weight bands (Fig. 3A) corresponding to CPS and co-extracted LOS, 191 
respectively (Karlyshev and Wren, 2001). As expected, the kpsM mutant lacked high 192 
molecular weight bands while production of LOS was not affected (Fig. 3A). In contrast, 193 
all heptose modification mutants formed CPS but mlghB::cat apparently produced less 194 
CPS than the others (Fig. 3A). Western blot analysis (with anti HS:2 Penner serotyping 195 
antibodies) of CPS samples obtained by SDS solubilization of total cells and proteinase K 196 
digestion of proteins (Hitchcock and Brown, 1983) also showed that all mutants tested 197 
produced CPS (Fig. 3B) and the amount produced by mlghB::cat was on par with all 198 
other strains. The differences in relative amounts seen for mlghB::cat by silver staining 199 
and Western blotting could relate to slight variations in CPS composition that could affect 200 
silver staining (Szymanski et al., 2003) and CPS solubility and recovery in the hot 201 
water/phenol extraction method, but compositional data below exclude this possibility. 202 
The differences probably rather relate to additional modifications of surface properties in 203 
this mutant, which may in turn affect extractability of the CPS by the hot water/phenol 204 
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method. Together, these results indicate that the absence of heptose or modified heptose 205 
does not prevent production of high molecular weight CPS. 206 
 Slight upwards shifts of CPS bands of the mutants were observed depending on 207 
loading amounts and gel composition. Because wild type C. jejuni CPS is anchored to the 208 
outer membrane via a phospholipid (Corcoran et al., 2006), the band shifts could reflect 209 
CPS anchoring to a different lipid carrier, such as lipid A, as seen in E. coli KLPS (Jann et 210 
al., 1992). To test this possibility, CPS samples were treated with phospholipase prior to 211 
SDS-PAGE analysis (Karlyshev et al., 2000). This led to disappearance of CPS bands in 212 
all strains tested (data not shown), demonstrating that CPS was phospholipid-bound. 213 
Also, in contrast to LOS bands, wild type and mutant CPS bands did not react with anti-214 
lipid A antibody (data not shown), confirming that CPS was not covalently linked to lipid 215 
A. We conclude that the band shifts represent subtle changes in CPS composition 216 
affecting not only the size of CPS units but also their hydrophobicity and ability to bind 217 
SDS. 218 
    219 
The CPS of heptose modification pathway mutants does not contain methylated heptose  220 
  221 
The composition of hot water/phenol extracted CPS was determined using a sugar 222 
analyzer after complete acid hydrolysis, and also using one- and two-dimensional NMR 223 
spectroscopy (Tables 1 and 2, Figs. S1 and S2). The data obtained, combined with data 224 
reported for C. jejuni NCTC 11168 CPS (McNally et al., 2007; St Michael et al., 2002; 225 
Szymanski et al., 2003), enabled inferring the CPS structures of wild type and mutant 226 
strains (Fig. 4). Sugar analysis revealed the three CPS backbone constituents, Rib, 227 
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GalNAc (detected as GalN) and GlcA in all strains. The higher than expected Rib/GalN 228 
ratios (expected equimolar) are likely due to RNA contamination of the samples. GlcA 229 
was not quantitated because it was amidated with EtN or GroN and was poorly released 230 
by hydrolysis but NMR spectroscopy analyses confirmed its presence by the 231 
characteristic signals for H-1 and C-1 in all strains (Table 2). Without authentic D-232 
glycero-L-gluco-heptose as standard, the presence or absence of heptose was inferred 233 
from signals for H-1 at δ 5.58 and C-1 at δ 98.3, which were observed in 
1
H and 
13
C 234 
NMR spectra of wild type CPS only (Table 2). Characteristic signals were also detected 235 
for 3-O-Me and 6-O-Me groups on heptose in wild type only (Fig S2), confirming that 236 
heptose was present and 3,6-di-O-methylated in wild type CPS while it was absent in the 237 
CPS from the mutants. 238 
 NMR spectroscopy did not reveal MeOPN modification in wild type CPS, but 239 
MeOPN was readily apparent on GalNAc in wcaG::cat and mlghB::cat (Table 2) and 240 
traces of MeOPN were found in mlghC::cat. Consistent with the deletion of MeOPN 241 
transfer genes in wcaG::cat∆, no MeOPN was detected in its CPS despite the presence of 242 
the GalNAc acceptor. Also, while the GlcA residue carried only the EtN substituent in 243 
wild type CPS, both EtN and GroN were found in the mutants (Table 1). These 244 
differences between wild type and heptose modification mutants could represent a 245 
compensatory mechanism whereby amidation of GlcA by GroN and/or MeOPN addition 246 
on GalNAc is enhanced when the production of D-glycero-L-gluco-heptose is impaired. 247 
No O-methyl groups were present in the complemented wcaG and mlghC mutants by 248 
NMR spectroscopy, suggesting that incorporation of wild type-like modified heptose was 249 
Page 11 of 74 Molecular Microbiology
For Peer Review
 
 12
not restored in these strains. The complemented mlghB strain was not tested by NMR 250 
spectroscopy for lack of sufficient CPS material. 251 
  252 
Inactivating heptose modification genes causes drastic changes in transcription within 253 
the CPS gene cluster 254 
  255 
The compensatory mechanisms inferred from NMR spectroscopy analyses in our mutants 256 
and lack of complementation of modified heptose incorporation in the CPS could result 257 
from polarity effects or from transcriptional regulation within the CPS cluster. We used 258 
quantitative real-time PCR (qRT-PCR) to demonstrate lack of polarity on expression of 259 
genes located downstream of the chloramphenicol (cat) and kanamycin (kan) resistance 260 
cassettes used for gene inactivation. Expression of the gene immediately downstream of 261 
kpsM in kpsM::kan or downstream of wcaG and mlghC in wcaG::cat and mlghC::cat, 262 
respectively was not affected (Fig. 5), indicating that insertion of the cat and kan 263 
cassettes was non-polar. However, in mlghB::cat, transcription of cj1429c directly 264 
downstream of mlghB was upregulated ~187-fold. Since th  cat cassette causes no 265 
polarity, we concluded that the upregulation of cj1429c transcription is related to 266 
inactivation of mlghB via a regulatory effect and not a mutagenesis artifact. Such 267 
transcriptional regulation implies the existence of promoters within the CPS cluster.  268 
 C. jejuni promoters are different from E. coli promoters (Wosten et al., 1998) and 269 
difficult to predict. To test for their existence, we measured the transcription levels of 270 
genes involved in CPS synthesis and modification by qRT-PCR. By doing so, we could 271 
also assess whether inactivation of one step during D-manno- to L-gluco- heptose 272 
Page 12 of 74Molecular Microbiology
For Peer Review
 
 13
conversion had any feedback regulatory effects on other steps or on other CPS 273 
modifications (e.g. MeOPN addition, amidation of GlcA, heptose methylation). 274 
Measurements were relative to housekeeping gene cj1537c (acetyl-CoA synthase) and 275 
accounted for primer efficiencies. 276 
 Expression levels varied considerably among the genes tested, with some too low 277 
to be quantitated accurately (e.g. kpsM), others on par with the housekeeping control, and 278 
others ~15-fold greater than control (Fig. 5A). The various transcription patterns 279 
observed indicate that numerous promoters exist within the CPS cluster. To further assess 280 
potential feedback regulatory effects of inactivation of one gene on surrounding genes, 281 
we analyzed the data as expression ratios between each mutant and the wild type (Pfaffl, 282 
2001) (Fig. 5B). This comparison indicated that inhibition of CPS transport by kpsM 283 
inactivation only had minor effects on heptose modification genes and no effects on the 284 
remaining CPS cluster genes tested, and that inactivation of biosynthesis/modification 285 
genes had little or no impact on transport functions. However, inactivation of mlghB or 286 
mlghC (responsible for heptose ring configuration switch from D-manno to L-gluco) led 287 
to upregulation of other genes involved in heptose synthesis and modification, including 288 
the O-methyl-transferase gene cj1426c (2.8- to 9.9-fold). Inactivation of mlghB or mlghC 289 
also strongly upregulated the transcription of cj1429c (186.7- and 18.1-fold, 290 
respectively), a gene of unknown function. Inactivation of wcaG produced different 291 
effects, with modest upregulation of heptose modification genes (2.9- to 4.5-fold), no 292 
effect on heptose synthesis and 60% reduction of transcription of cj1429c. These 293 
differences could be due to the previously established regulatory role of WcaG on 294 
heptose modification by substrate scavenging and interaction with MlghC (McCallum et 295 
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al., 2011; McCallum et al., 2012; McCallum et al., 2013). Together, the transcriptional 296 
data suggest that inactivation of wcaG, mlghB, or mlghC or the absence of their products 297 
exert regulatory effects on other CPS modification genes, which may influence the 298 
functional properties of CPS. 299 
 We next assessed whether these regulatory effects were abrogated in our 300 
complemented strains, focusing on the mlghC and mlghB mutants that showed the 301 
strongest regulatory effects above. Reintroduction of mlghC into the mlghC mutant led to 302 
60+-1.5 fold up-regulation of mlghC compared to wild type, mirrored by 67+-3.8 fold up-303 
regulation of mlghB upon its reintroduction into the mlghB mutant. While such high 304 
transcription levels had no significant effects on transcription of other CPS genes such as 305 
wcaG and mlghB in the complemented mlghC strain (with 1.9+-0.3 and 0.4+-0.1 fold 306 
compared to wild type, respectively), wcaG and mlghC were upregulated 5.4+-0.3 and 307 
8.5+-0.4 fold compared with wild type, respectively, in the complemented mlghB strain, 308 
which may affect CPS composition and function. Overall, this analysis indicates that the 309 
strong OmpE promoter and internal promoters in the CPS cluster result in significant 310 
transcriptional differences in complemented strains, which together with enzymatic 311 
regulatory loops (McCallum et al., 2013) may explain the lack of functional 312 
complementation of the mutants observed by NMR. Others have also reported previously 313 
similar difficulties with complementation upon perturbation of regulatory networks or 314 
improper stoichiometry of enzymes involved in polysaccharide synthesis (van Sorge et 315 
al., 2014). Therefore, in view of these difficulties and since qRT-PCR data demonstrated 316 
lack of polarity of the mutations, we did not pursue the characterization of the 317 
“complemented” strains. 318 
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 319 
Disruption of heptose modification pathway affects growth rate and decreases motility 320 
but does not affect autoagglutination  321 
 322 
When measuring growth rates of wild type and mutants under microaerobic conditions, 323 
we observed that the heptose modification mutants grew consistently faster than wild 324 
type. The wcaG::cat∆ mutant, which not only lacks heptose in its CPS but also lacks 325 
MeOPN on GalNAc (Fig. 6A), reached the highest final cell density. This suggests that 326 
implementation of the heptose modification pathway (configuration switch, and 327 
methylation) and of the MeOPN addition pathway imposes an energetic cost. The 328 
kpsM::kan mutant exhibited a longer lag phase before entering exponential phase, 329 
suggesting that the accumulation of CPS units or CPS precursors inferred from the qRT-330 
PCR analysis above may be slightly toxic to the bacterium, as observed in comparable 331 
mutants of other species (Kroll et al., 1988; Pavelka et al., 1994). 332 
 We also investigated if alteration of CPS amount or composition in the mutants 333 
could affect autoagglutination, which was measured as the decrease of turbidity over time 334 
in the upper level of static bacterial suspensions. Autoagglutination occurred in all strains 335 
and there was no significant difference between wild type and the heptose modification 336 
mutants (Fig. 6B). In contrast, kpsM::kan showed increased autoagglutination (Fig. 6B) 337 
and microscopy revealed that this mutant formed clumps of cells (Fig. 6C). Motility was 338 
assessed in soft agar to determine if impaired motility contributed to the strong 339 
autoagglutination of kpsM::kan. This mutant was nonmotile while the heptose 340 
modification mutants were motile, albeit at a statistically significantly reduced rate 341 
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compared to wild type (Table 3). Electron microscopy revealed that the majority of 342 
kpsM::kan cells produced flagella similar to the wild type strain (Fig. 6D), suggesting that 343 
loss of motility was due to a defect in flagellar function. Overall, the total lack of motility 344 
of kpsM::kan may contribute to its autoagglutination. 345 
 346 
Disruptions of heptose modification pathway alters CPS barrier function 347 
  348 
CPS contributes to resistance to bile salts in many bacteria (Begley et al., 2002; Hsieh et 349 
al., 2003; Pace et al., 1997). We tested whether CPS and its modified heptose contribute 350 
to resistance to bile salts for C. jejuni. Wild type and mutant strains were exposed to 351 
increasing concentrations of a mixture of cholic and deoxycholic acids, two abundant bile 352 
salts in humans. Low concentrations (0-0.25 g/l) of bile salts had little effect on all strains 353 
(Fig. 7A). However, higher concentrations (0.5-2.0 g/l) resulted in 80-90% killing in the 354 
wild type strain. Interestingly, kpsM::kan was as susceptible to bile salt killing as wild 355 
type, indicating that CPS as a whole and in its wild type structure and composition does 356 
not contribute to resistance. Likewise, wcaG::cat∆ and wcaG::cat had wild type like bile 357 
salts susceptibility while mlghC::cat and mlghB::cat were more resistant (p<0.001) than 358 
wild type. These differences in bile salts resistance may reflect subtle differences in the 359 
CPS, which may not be apparent in NMR analyses of CPS extracted from the mutants 360 
since the mutants had similar NMR profiles, except for a lower MeOPN content in 361 
mlghC::cat and lack of MeOPN in wcaG::cat∆. The observed differences for mlghB::cat 362 
and mlghC::cat were specific to bile salts, as no differences in resistance to SDS were 363 
observed for these mutants or with any of the others. 364 
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 CPS protects bacteria against killing by serum, including in C. jejuni 81-176 365 
(Maue et al., 2013). We investigated whether alterations of CPS composition in our 366 
mutants would affect resistance to serum killing. The wild type exhibited 40% survival 367 
after 90 min in 30% serum, while non-capsular kpsM::kan did not survive in 5% serum 368 
(Fig. 8A), indicating that wild type CPS protects C. jejuni against serum killing. The 369 
wcaG::cat and wcaG::cat∆ mutants were resistant to up to 5% serum but highly 370 
susceptible to concentrations above 20%, while mlghB::cat  and mlghC::cat displayed 371 
intermediate susceptibility, resisting killing up to ~15% of serum, but being killed by 372 
more than 30% serum (Fig. 8A). Time-course experiments were performed using 20% 373 
serum, a concentration where maximal differences were observed between strains (Fig. 374 
8B). The kpsM::kan and wcaG::cat∆ mutants were killed very rapidly while wcaG::cat 375 
resisted slightly longer (Fig. 8B). Together, these results demonstrate that heptose in its 376 
3,6-O-Me2-L-gluco form, as present in wild type, is essential for CPS-mediated protection 377 
against serum killing. In contrast, mlghC::cat showed wild type killing kinetics for the 378 
first 45 min, with a slightly lower survival afterwards (Fig. 8B). Since the only difference 379 
between the CPS of mlghC::cat and wcaG::cat is the lower amount of MeOPN in 380 
mlghC::cat, we conclude that MeOPN is actually deleterious for resistance to serum 381 
within the context of heptose-less mutants. This agrees with the observation that wild 382 
type does not produce MeOPN under our growth conditions. Unexpectedly, mlghB::cat 383 
resisted killing better than all strains including wild type for about 45 min, but plummeted 384 
beyond that time to reach wild type levels at 90 min. Because we could not distinguish 385 
the CPS of mlghB::cat from that of wcaG::cat by NMR spectroscopy or Western blotting, 386 
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their different serum resistance may reflect additional differences in surface properties in 387 
the mlghB::cat mutant.   388 
  389 
Disruption of heptose modification pathway does not affect interactions with RAW 264.7 390 
macrophages 391 
 392 
Several studies have suggested that C. jejuni can survive within murine macrophages for 393 
several days (Day et al., 2000; Kiehlbauch et al., 1985; Mixter et al., 2003). To test 394 
whether the CPS and its modified heptose protect C. jejuni against intracellular killing, 395 
the CPS mutants were assayed for survival in RAW 264.7 macrophages. Intracellular 396 
survival decreased drastically within a few hours and there was no statistically significant 397 
difference between wild type and any of the mutants whether the data were analyzed as 398 
percent of original inoculum (Fig. S3A) or percent of initial bacterial load (Fig. S3B), 399 
Likewise, no significant differences were observed between heptose modification 400 
mutants and wild type regarding adhesion and phagocytosis rates (Fig. S3C and S3D). 401 
These data indicate that the modified heptose does not prot ct against adhesion, uptake or 402 
clearance by macrophages. A slight anti-phagocytic role could nevertheless be attributed 403 
to wild type CPS as kpsM::kan was engulfed at higher levels than wild type when 404 
interactions were allowed to proceed for at least 2 h (Fig S3D). 405 
 406 
The heptose modification pathway is important for invasion of intestinal epithelial cells  407 
  408 
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Adhesion to intestinal epithelial cells and their invasion are important for C. jejuni 409 
pathogenicity (Black et al., 1988; De Melo et al., 1989; Fauchere et al., 1986; Konkel et 410 
al., 1992) and CPS is thought to be essential for these processes (Bachtiar et al., 2007; 411 
Bacon et al., 2001). We therefore assessed our mutants for adhesion and invasion with 412 
Caco-2 intestinal epithelial cells. The heptose modification mutants adhered at wild type 413 
levels, indicating no role of heptose modification in adhesion (Fig. 9A). Differences 414 
among heptose modification mutants were observed for invasion, with abrogated invasion 415 
for mlghB::cat and mlghC::cat, wild type invasion for wcaG::cat, and increased invasion 416 
for wcaG::cat∆. Finally, kpsM::kan was more adhesive and invasive than wild type. 417 
Phase contrast microscopy showed that it agglutinated on the surface of Caco-2 cells, 418 
which could enhance adhesion, while other mutants did not (data not shown). 419 
  420 
The heptose modification pathway is important for colonization and persistence in 421 
chicken intestine 422 
 423 
C. jejuni wild type and mutants were tested for their ability to colonize the intestine of 424 
two day old chicks. All mutants were significantly impaired for colonization and/or 425 
persistance in the chicken intestinal tract compared to wild type, but differences were also 426 
observed between the mutants (Fig. 10). Specifically, wcaG::cat∆ and mlghC::cat 427 
demonstrated a median 5.4 log (p<0.0001) and 6.3 log (p<0.0001) reduction in 428 
colonization compared to wild type, respectively. In addition, while infection of all 429 
inoculated chicks was observed with wild type, wcaG::cat∆ and mlghC::cat were only 430 
isolated from 6 of 11 (54.5%) and 4 of the 12 (25%) inoculated chicks, respectively. In 431 
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contrast, bacteria were isolated from all chicks infected with mlghB::cat and kpsM::kan 432 
and in 12 out of 14 chicks inoculated with wcaG::cat. All these mutants also persisted 433 
significantly less than wild type and demonstrated medians of 1.9 log (p=0.0001), 1.1 log 434 
(p=0.0231) and 1.8 log (p=0.0095) reduction in colonization when compared to wild 435 
type, for mlghB::cat, kpsM::kan and wcaG::cat respectively. The data indicate that in C. 436 
jejuni ATCC 700819, CPS is important but not essential for colonization of the chick 437 
intestine. We speculate that underlying adhesins compensate for the lack of CPS. 438 
However, when CPS is present, its wild type composition featuring the modified heptose 439 
appears optimal for colonization of the chicken intestinal tract. 440 
 441 
DISCUSSION 442 
 443 
To assess the role of the role of heptose and its modification in CPS function, we 444 
performed a detailed analysis of C. jejuni mutants of the wcaG, mlghB, and mlghC genes, 445 
which affect the switch of CPS heptose from a D-manno to a L-gluco form (McCallum et 446 
al., 2013). Our results showed that these genes play unexp cted roles in transcriptional 447 
regulation within the CPS cluster. The C. jejuni CPS cluster is similar to group II and III 448 
CPS clusters of E. coli, whereby conserved CPS transport regions 1 and 3 flank the sugar 449 
synthesis region 2 (Karlyshev et al., 1999; Whitfield and Roberts, 1999). Region 3 in the 450 
E. coli K5 CPS cluster has a σ70 promoter (upstream of kpsM included in this region) 451 
and RfaH-dependent read-through transcription from this promoter into region 2 is 452 
essential for CPS production (Rowe et al., 2000; Stevens et al., 1997). If this also applied 453 
to C. jejuni, genes from regions 2 and 3 would be transcribed at similar levels or with 454 
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decreasing levels as their distance from the region 3 promoter increases, without 455 
differential regulation of gene expression within region 2. However, we observed 456 
differential transcription of CPS modification genes in the wild type strain, which is 457 
likely important to fine tune the CPS composition as C. jejuni passes from one host to 458 
another or is exposed to the environment, as the modified heptose, MeOPN and 459 
methylation may each enhance resistance to different adverse conditions. The qRT-PCR 460 
data imply the existence of internal promoters within regions 2 and 3, which agrees with 461 
a recent RNA-seq study (Dugar et al., 2013). Transcriptional start sites were identified by 462 
RNA-seq upstream of cj1445c, cj1444c, and cj1425c to cj1429c, which was consistent 463 
with our qRT-PCR findings. This RNA-seq study identified a start site for cj1447c within 464 
kpsM in two strains but not in the strain NCTC 11168 used in our study. We show that 465 
transcription of kpsM can vary without affecting that of cj1447c, indicating that the start 466 
site for cj1447c is also present in strain NCTC 11168. 467 
 468 
Implications of heptose modification pathway disruption for CPS composition 469 
 470 
While it had already been shown that a mlghC::cat mutant produces heptoseless CPS (St 471 
Michael et al., 2002), as we also observed in our study, the CPS composition in 472 
wcaG::cat∆, wcaG::cat and mlghB::cat mutants had to be determined. We found no 473 
heptose in wcaG::cat∆ by NMR spectroscopy analysis, as expected from deletion of its 474 
heptose biosynthesis genes. Like for mlghC::cat, we also found no modified heptose in 475 
wcaG::cat and mlghB::cat. The lack of even an unmodified heptose in these mutants 476 
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despite their ability to synthesize GDP-D-glycero-D-manno-heptose is consistent with the 477 
generally high specificity of glycosyltransferases involved in CPS assembly. 478 
 SDS-PAGE analysis indicated that except for kpsM::kan, CPS production was not 479 
abrogated in the mutants, and lack of heptose did not prevent CPS polymerization. 480 
Further, all mutants produced comparable amounts of CPS, although lower hot 481 
water/phenol extractability of the CPS produced by mlghB::cat was observed. This 482 
difference in CPS extractability along with its enhanced serum resistance despite equal 483 
CPS composition and production suggest additional differences in surface properties in 484 
this mutant. It is possible that such additional differences could be mediated by the 485 
striking ~187 fold upregulation of cj1429c that is observed in this mutant only.  486 
 The upregulation of the putative heptose methyl-transferase gene in all mutants 487 
shown by qRT-PCR did not result in incorporation of methyl heptose in the CPS, as 488 
shown by NMR spectroscopy. This could indicate that either methylation occurs after the 489 
heptose configuration switch or that methylated manno-heptose is not recognized as a 490 
substrate by glycosyltransferases for incorporation into CPS. NMR spectroscopy analysis 491 
also showed that the MeOPN modification was strongly upregulated in heptose 492 
biosynthesis mutants, which may affect the biological function of their CPS. 493 
   494 
Role of modified heptose on barrier function of CPS  495 
 496 
C. jejuni can resist physiological levels of bile salts (0.1-21 mM) (Lin et al., 2003; Lin et 497 
al., 2005) and has been isolated from the gall bladder and bile (Gerritsen van der Hoop 498 
and Veringa, 1993; Udayakumar and Sanaullah, 2009). In Listeria monocytogenes and 499 
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Vibrio parahaemolyticus, upregulation of CPS genes upon exposure to bile salts suggests 500 
a role of CPS in bile resistance (Begley et al., 2002; Pace et al., 1997). Therefore, we 501 
determined whether CPS as a whole, or its modified heptose, contributes to resistance of 502 
C. jejuni to bile salts. The concentrations tested (0.25 to 2 g/l) amount to ~ 0.6 to 4.8 mM 503 
and fall within the physiological ranges previously reported (Campbell et al., 2004; Lin et 504 
al., 2003; Perez de la Cruz Moreno et al., 2006). The wild type-like susceptibility of 505 
kpsM::kan suggests that wild type CPS does not provide resistance against bile salts, and 506 
the enhanced resistance of the mlghB and mlghC mutants showed that heptose and its 507 
modification as present in wild type CPS actually rendered the strain more susceptible to 508 
bile salts. Therefore, the cumulative effects of lack of heptose and methylation, and 509 
variations in MeOPN, GroN and EtN contents observed in the mutants, could alter the 510 
bacterial surface hydrophobicity and confer slight protective function to CPS via 511 
enhanced repulsion of bile salts. 512 
Serum complement is an essential innate immune defense against pathogens and 513 
the sensitivity of C. jejuni strain 81-176 to serum is mitigated by its CPS (Maue et al., 514 
2013) as also reported for Salmonella typhi, Klebsiella pneumoniae, and B. pseudomallei 515 
(Cortes et al., 2002; Hashimoto et al., 1993; Reckseidler-Zenteno et al., 2005). Our 516 
kpsM::kan mutant confirmed an essential role of CPS in protection against serum in our 517 
strain, and the heptose modification mutants showed that the modified heptose in its wild 518 
type form is essential for protection. Killing of C. jejuni by serum involves activation of 519 
the classical complement pathway (van Alphen et al., 2014) but we do not know if C. 520 
jejuni CPS and modified heptose interfere with deposition of critical C3 complement 521 
component as observed in other pathogens (Vogel et al., 1997; Woodman et al., 2012). 522 
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As mentioned above, the slower kinetics of killing of mlghB::cat at low serum 523 
concentration may be due to additional modifications in surface properties since no 524 
obvious differences were seen in its CPS. Also, we showed a slightly deleterious effect of 525 
MeOPN, which increased serum susceptibility in the absence of heptose. Thus the role of 526 
MeOPN in serum resistance appears to depend on other CPS components, which may 527 
explain prior conflicting results (Maue et al., 2013; van Alphen et al., 2014). Finally, the 528 
protective function of CPS against serum killing may depend on other surface 529 
components such as LOS since a LOS mutant lacking sialic acid is serum sensitive 530 
despite the presence of CPS in strain 81-176  (Guerry et al., 2000; Guerry et al., 2002). 531 
All our mutants produce LOS and the serum sensitivity of kpsM::kan (that produces LOS 532 
but no CPS) shows that LOS does not confer protection against serum killing in strain 533 
ATCC 700819. This is consistent with prior studies indicating no role of LOS in serum 534 
resistance (Bacon et al., 2001; Keo et al., 2011). 535 
 536 
Role of CPS and modified heptose on interactions with macrophages and epithelial cells 537 
 538 
In contrast to prior reports (Day et al., 2000; Kiehlbauch et al., 1985; Mixter et al., 2003), 539 
we did not observe prolonged survival of C. jejuni in murine RAW 267.4 macrophages 540 
and wild type capsule production did not affect intracellular survival or initial adhesion 541 
but decreased phagocytosis as determined by comparing wild type to non-capsular 542 
kpsM::kan. The sharp increase in phagocytosis of kpsM::kan coincided with its 543 
agglutination and likely resulted from phagocytosis of clumps of bacteria. It could also be 544 
due to exposure of adhesins that are masked by the CPS layer in wild type. 545 
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The heptose-modification mutants showed that heptose modification and MeOPN 546 
addition (that also varies in these mutants) played no role in macrophage / bacteria 547 
interactions. Thus, the true biological role of CPS modified heptose is not resistance to 548 
clearance by murine macrophages. Different effects may be observed with human or 549 
avian macrophages, and may explain the host-dependent pathogenic versus commensal 550 
character of C. jejuni. 551 
 We showed that C. jejuni ATCC 700819 adhered to and invaded Caco-2 cells at a 552 
very low rate, consistently with prior reports (Ashgar et al., 2007; Carrillo et al., 2004; 553 
Everest et al., 1992; Ganan et al., 2010; Szymanski et al., 1995; Vijayakumar et al., 554 
2006). In contrast to what was observed in strain ATCC 81-176 (Bacon et al., 2001), our 555 
non-capsular kpsM::kan mutant showed increased adhesion and invasion of Caco-2 cells 556 
(Fig. 9). Unmasking of adhesins and autoagglutination may each contribute to this 557 
phenomenon. The presence of CPS, which limits adhesion to low levels, may prevent 558 
overt tissue damage that could lead to faster bacterial clearance. 559 
 Although heptose is essential for adhesion of pathogenic E. coli to HeLa cells 560 
(Benz and Schmidt, 2001), our data indicate that C. jejuni CPS heptose is not important 561 
for adhesion to Caco-2 cells. Variable levels of invasion were observed for the heptose 562 
modification mutants but did not correlate directly with NMR structural data concerning 563 
heptose and MeOPN contents. For example, abrogated invasion for mlghB::cat and 564 
mlghC::cat could suggest a role for modified heptose in cell invasion, but the wild type-565 
like and enhanced invasion of heptoseless wcaG::cat and  wcaG::cat∆, respectively, does 566 
not support this. Likewise MeOPN presence or abundance could not be correlated with 567 
invasion, although MeOPN contributes to epithelial cell invasion in strain 81-176 (van 568 
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Alphen et al., 2014). The variations of invasion however correlated well with the levels 569 
of transcription of cj1429c in the mutants, and may be due to additional surface 570 
differences mediated by cj1429c. The increased invasion of wcaG::cat∆ despite its lack 571 
of heptose and MeOPN also suggests that additional components contribute to the 572 
process. The data nevertheless indicate that interferences with heptose modification affect 573 
invasion. Since invasion can promote tissue damage, transepithelial transport and 574 
protection against clearance, our data suggest that the heptose modification pathway is 575 
important for host colonization and pathogenicity. 576 
 577 
Role of CPS and modified heptose on colonization of chicken intestinal tract 578 
  579 
The chick intestinal colonization data with kpsM::kan showed that CPS of strain 700819 580 
is not essential to establish an infection since all chicks were colonized. This agrees with 581 
data obtained with a CPS export mutant of strain ATCC 81116 (Bachtiar et al., 2007). 582 
These data do not negate a role for CPS in colonization but may reflect the fact that 583 
unmasked adhesins could compensate for lack of CPS. In addition, our data with 584 
kpsM::kan showed that CPS was important for persistence since a 1.6 log reduction of 585 
caecum load was observed. This attenuation differs from another study which showed 586 
that a kpsM mutant could not persist at all in the chicken intestine (Jones et al., 2004). 587 
The discrepancy could be due to the use of a hypermotile strain (NCTC 11168H) and of 588 
2-week-old chickens that present a more mature gut microflora. 589 
 Flagella-mediated motility enhances intestinal colonization by C. jejuni (Biswas 590 
et al., 2007; Wassenaar et al., 1997) but is not essential (Biswas et al., 2007; Wassenaar 591 
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et al., 1993) as confirmed by colonization of all chicks tested by our non-motile 592 
kpsM::kan. The flagellar apparatus also serves as a secretion system for C. jejuni invasion 593 
antigens (Cia), which facilitate colonization and persistence (Konkel et al., 1999; Konkel 594 
et al., 2004). The kpsM::kan mutant assembled flagella, indicating that it has the 595 
apparatus required for Cia secretion and should thus be able to colonize and persist within 596 
the intestinal tract as observed. Also, the increased exposure of adhesins in the absence of 597 
CPS may compensate for the lack of motility of this mutant. 598 
The data obtained for our heptose modification mutants show a role of modified 599 
heptose in colonization and persistence. Indeed wcaG::cat∆ and mlghC::cat were 600 
impaired both in colonization (less chicks colonized than wild type) and persistence 601 
(lower load than wild type), while wcaG::cat and mlghB::cat showed mostly defects in 602 
persistence (most chicks colonized but at lower levels) (Fig. 10). We assume that the 603 
effects are due to the modified heptose independently of MeOPN since a MeOPN 604 
transferase mutant of strain 81-176 showed wild type-like chicken colonization (van 605 
Alphen et al., 2014), although strain-specific differences cannot be excluded. While all 606 
heptose modification mutants were less motile than wild type, we exclude that their 607 
decreased colonization was due to decreased motility since the kpsM::kan data indicated 608 
that the contribution of motility to colonization was limited in this model. Also, the 609 
bacterial suspensions used for inoculation were adjusted to the same OD to alleviate 610 
interferences from different growth rates, and the highest bacterial load was actually 611 
recovered with the slowest growing strain (kpsM::kan). Thus factors other than growth 612 
and motility were critical for gut colonization and persistence in our heptose mutants. 613 
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 Overall, our data indicate that CPS and its heptose affect the efficiency of chicken 614 
gut colonization and persistence. It is likely that C. jejuni modulates CPS expression and 615 
composition in vivo at different stages of colonization as seen in other intestinal 616 
pathogens such as, for example, the Vi-antigen of S. typhi (Jones et al., 2004). This is 617 
plausible for C. jejuni as expression of CPS is phase variable (Bacon et al., 2001) and co-618 
culture of C. jejuni with epithelial cells reduces surface CPS expression, thereby 619 
highlighting the dynamic role of CPS in interactions with host cells (Corcionivoschi et 620 
al., 2009). Our data suggest that suppressed CPS expression during infection exposes 621 
surface adhesins that lead to increased agglutination of C. jejuni, facilitating adhesion in 622 
clumps and increasing invasion. Resumed CPS production and fine-tuning of its 623 
composition may favor persistence at other stages of infection, affecting differentially its 624 
barrier functions and its effects on intracellular survival. Our discovery of internal 625 
promoters that likely allow transcriptional optimization of CPS composition in response 626 
to environmental stimuli is in line with this hypothesis. 627 
 Collectively, the data presented in this study indicate a role of wcaG, mlghB, and 628 
mlghC in determining CPS composition and biological function. The mutants 629 
demonstrate very different behaviors in terms of CPS barrier functions, interactions with 630 
different cell types and motility, which culminate in different outcomes concerning 631 
colonization and persistence in the chicken intestinal tract. Overall, fine tuning of CPS 632 
composition via modified heptose incorporation and other modifications that seem to be 633 
interdependent with heptose modification, allows reaching an optimal configuration that 634 
contributes to survival of the bacterium when confronted with various host defenses 635 
along the gastrointestinal tract (bile salts, serum and phagocytic cells) and also 636 
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contributes to persistence of the bacterial population via invasion of intestinal cells. This 637 
investigation illustrates the impact that altering CPS composition can have on CPS 638 
function and on the virulence of encapsulated bacteria and suggests that the enzymes 639 
responsible for the biosynthesis of CPS components such as the modified heptose could 640 
be suitable targets for future therapeutic research. 641 
 642 
 643 
EXPERIMENTAL PROCEDURES 644 
Bacterial culture conditions 645 
 646 
All experiments were carried out with strain NCTC 11168 / ATCC 700819 (HS: 2 Penner 647 
serotype). C. jejuni was grown in a microaerobic atmosphere (85% N2, 10% CO2, and 5% 648 
O 2) at 37˚C on Trypticase Soy Agar (TSA) supplemented with 5% sheep blood and 10 649 
µg/ml vancomycin and 5 µg/ml trimethoprim as background antibiotics. Where 650 
appropriate, the medium was supplemented with 15 µg/ml chloramphenicol or 30 µg/ml 651 
kanamycin. Unless stated otherwise, C. jejuni was grown overnight from freezer stock on 652 
TSA containing appropriate antibiotics, followed by a further growth on TSA containing 653 
only the background antibiotics for 20-24 hours. The cells were harvested and normalized 654 
to the same OD600nm before use for phenotypic analyses. Viability of the bacterial 655 
suspensions used as inoculum for phenotypic assays was assessed by CFU measurements. 656 
For transformation, C. jejuni was grown on Mueller Hinton (MH) agar (BD, Canada), 657 
containing 10 µg/ml vancomycin, 5 µg/ml trimethoprim, 0.05% pyruvate, and 5% heat 658 
inactivated Fetal Bovine Serum (Sigma Aldrich). E. coli strain DH5α was used for 659 
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cloning and was grown in Luria Bertani medium. When necessary, 100 µg/ml ampicillin, 660 
30 µg/ml kanamycin, or 34 µg/ml chloramphenicol were added. 661 
 662 
Preparation of knockout constructs 663 
 664 
The wcaG (a.k.a. cj1427c), mlghC (a.k.a. cj1428c),  mlghB (a.k.a. cj1430c) and kpsM 665 
(a.k.a. cj1448c) genes were amplified via Polymerase Chain Reaction (PCR) from 666 
chromosomal DNA of C. jejuni strain ATCC 700819 using primers cj1427c P2/P3, 667 
cj1428c P2/P3, cj1430c P2/P3, and kpsM P2/P3 (Table 4). The PCR was performed using 668 
Expand Long Range DNA polymerase (Roche) according to Manufacturer’s instructions. 669 
For wcaG, mlghB and mlghC, the PCR products were cut with BamHI and NcoI and were 670 
ligated to a pET23 vector derivative (Newton and Mangroo, 1999) that had been cut with 671 
the same enzymes. The kpsM gene was cloned into the EcoRV site of pBluescript KS(+), 672 
following blunting of the PCR product by T4 DNA Polymerase (Roche, Canada). After 673 
transformation of ligation reactions into E. coli DH5α and selection on ampicillin, the 674 
resulting plasmids (pET/wcaG, pET/mlghC, pET/mlghB and pBluescriptKS/kpsM) were 675 
extracted and checked by DNA sequencing (Robarts Research Institute, London, 676 
Ontario). 677 
Disruption constructs were generated by performing inverse PCR on pET/wcaG, 678 
pET/mlghC, pET/mlghB using primers cj1427c P4/P5, cj1428c P4/P5, cj1430c P4/P5, 679 
which contain KpnI and ApaI sites. The chloramphenicol resistance cassette (cat) was 680 
amplified from plasmid pRY111 (kindly provided by P. Guerry, Naval Medical Research 681 
Center, MD, USA) using primers Catcoli P2 and CatColi P3 which contained ApaI and 682 
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KpnI sites, respectively. The amplicon was subsequently ligated into the inverse PCR 683 
reaction products following ApaI and KpnI digestion. The constructs were introduced 684 
into E. coli DH5α and transformants were selected on ampicillin and chloramphenicol. 685 
The resulting pET/wcaG::cat, pET/mlghC::cat, and pET/mlghB::cat, constructs were 686 
extracted and checked by DNA sequencing. For the disruption of kpsM, inverse PCR was 687 
used to amplify pBluescriptKS/kpsM with the primers kpsM P4/P6 that contain BglII and 688 
NcoI sites, respectively. The kanamycin resistance cassette (kan) was amplified from 689 
plasmid pHel3 (Heuermann and Haas, 1998) using Aph3P1 and Aph3P2, which also 690 
contained BglII and NcoI restriction sites. The kan cassette was subsequently ligated into 691 
the pBluescriptKS/kpsM inverse PCR reaction product after BglII/NcoI digestion. 692 
Following E. coli DH5α transformation, transformants were selected on ampicillin and 693 
kanamycin. The resulting pBluescriptKS/kpsM::kan construct was checked by DNA 694 
sequencing. 695 
 696 
Generation of knockout mutants in C. jejuni ATCC 700819  697 
 698 
The wcaG::cat, mlghB::cat, mlghC::cat, and kpsM::kan fragments were amplified using 699 
gene specific primers P2 and P3 (Table 4) containing NcoI and BamHI restriction sites 700 
respectively. C. jejuni chromosomal DNA digested with the same restriction enzymes 701 
was ligated to either end of the PCR fragments. The DNA was introduced into C. jejuni 702 
via natural transformation using 0.03% saponin (Nuijten et al., 1989; Vijayakumar et al., 703 
2006). Potential transformants were selected on MH agar containing 15 µg/ml 704 
chloramphenicol or 30 µg/ml kanamycin, The transformants were checked by PCR using 705 
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gene specific and antibiotic cassette specific primers, as well as by Southern blotting 706 
using digoxigenin (Roche) labeled DNA probes. 707 
As an alternative to obtain the wcaG mutant, the pET/wcaG::cat was methylated 708 
in vitro as described by others (Donahue et al., 2000). Ten µg of plasmid DNA were 709 
treated with a cell-free extract of C. jejuni (containing 300-400 µg of proteins) in the 710 
presence of 200 nM S-adenosyl methionine (Sigma Aldrich). Methylation was carried out 711 
at 37°C for 1 hour in “methylation” buffer (20 mM Tris-acetate (pH 7.9), 50 mM 712 
potassium acetate, 5 mM Na2EDTA, 1 mM dithiothreitol (DTT)) in a total volume of 200 713 
µl. To obtain a cell-free extract, wild type C. jejuni was harvested from five TSA plates 714 
and resuspended in 4 ml of “methylation” buffer supplemented with protease inhibitor 715 
cocktail (Roche). This was passed through a French pressure cell press (Thermo 716 
Scientific) five times. The amount of protein in the cell-free extract was quantitated by 717 
Bradford Assay (Bradford, 1976). Following methylation, phenol:chloroform:isoamyl 718 
alcohol (in a 25:24:1 v:v:v ratio) was used to purify the DNA which was concentrated by 719 
sodium acetate/ethanol precipitation. The plasmid was introduced in C. jejuni by natural 720 
transformation as above, using 70 µl of cells resuspended at 10E9 cells/ml and 2 µg of 721 
DNA in a total volume of 80 µl, with recovery of ~ 8-10 h prior to selection on 722 
chloramphenicol. 723 
 724 
Preparation of complemented strains 725 
 726 
Complementation was performed by chromosomal integration in the 16S - 23S rRNA 727 
region as reported previously (Karlyshev and Wren, 2005). All primers used are listed in 728 
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Supplementary Table 1. The 16S – 23S rRNA region was amplified from genomic DNA 729 
using primers 16SrRNATop and 23SrRNABottom and was inserted into the KpnI/NotI 730 
sites of pBluescript KS (+). Clones were obtained using E. coli DH5α and selection with 731 
ampicillin. Separately, the primer overlap extension method (Heckman and Pease, 2007) 732 
was used to fuse each gene of interest to the ompE promoter and to a kan resistance 733 
cassette. The promoter was amplified using primer ompEFor combined with 734 
ompERev1427, ompERev1428, or ompERev1430. The genes to be complemented were 735 
amplified using primer pairs 1427ForOmpE / 1427RevKan, 1428ForOmpE / 736 
1428RevKan, or 1430ForOmpE / 1430RevKan. The kan cassette was amplified using 737 
primer AphP3 combined with KanFor1427, KanFor1428 or KanFor1430. All fragments 738 
were fused together by PCR using standard conditions. The fusions were then inserted 739 
into the XbaI site of the 16S–23SrRNA-containing vector from above to generate the 740 
final complementation constructs. Clones were selected with ampicillin and kanamycin 741 
and sequenced (Robarts Sequencing Facility, London, Ontario). The constructs were 742 
transformed into their respective mutants following in vitro methylation as reported 743 
above. Clones were selected on ampicillin and kanamycin and analysed by PCR to check 744 
integration of the constructs. 745 
 746 
Real-time PCR analyses 747 
 748 
Messenger RNA was extracted from C. jejuni using the GE-Healthcare mRNA midiprep 749 
kit, and cDNA synthesis was performed using the Biorad cDNA biosynthesis kit and 750 
random hexanucleotides following Manufacturer’s instructions. Real-time PCR was 751 
performed on a Rotor-Gene 6000 (Corbett Life Science, Canada) using SYBR green 752 
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Supermix (Biorad) and gene-specific primers (Table 4). The optimal annealing 753 
temperature and primer concentrations were determined for each gene. The primer 754 
efficiencies were determined from standard curves established using serial dilutions of 755 
genomic DNA under optimal annealing temperature and primer concentrations. Negative 756 
controls for the reverse transcription did not contain the reverse transcriptase, while 757 
negative controls for the real time PCR did not contain template cDNA. The relative gene 758 
expression for each gene was calculated using the Pfaffl equation (Pfaffl, 2001): 759 
Ratio = (Etarget)
∆CTtarget(WT-mutant)
/(Ereference)
∆CTref(WT-mutant)
. 760 
 In this equation, target refers to the gene being studied and the reference is the 761 
housekeeping cj1537c gene, which encodes acetyl-CoA synthase (Parkhill et al., 2000). E 762 
is the primer efficiency, and CT corresponds to the number of PCR cycles necessary to 763 
observe a fluorescence signal above a set threshold. 764 
 765 
SDS-PAGE and Western blotting analysis of CPS 766 
 767 
Total surface carbohydrates (CPS and LOS) were extracted via SDS solubilization of C. 768 
jejuni cells (Hitchcock and Brown, 1983), followed by digestion of proteins by proteinase 769 
K treatment. They were separated on a 15% SDS-PAGE 5 cm mini gel and analyzed by 770 
Western blotting using Penner serotyping antibody HS:2 (kindly provided by Dr. M. 771 
Karmali, Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Guelph, 772 
Ontario) since strain ATCC 700819 belongs to the HS:2 Penner serotype (Karmali et al., 773 
1983; Penner et al., 1983) and CPS contributes to serotype specificity (Karlyshev et al., 774 
2000). Detection was performed with a fluorescently labeled anti-rabbit secondary 775 
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antibody (IRDye 680 Goat Anti-Rabbit, Licor Biosciences) on an Odyssey Infrared 776 
Imaging system (Licor Bioscience). Alternatively, CPS was extracted by hot water 777 
phenol (see below), ran on a 13 cm long gel and detection was performed by silver 778 
staining (Fomsgaard et al., 1990). 779 
 780 
CPS isolation by the hot water phenol method 781 
 782 
C. jejuni ATCC 700819 wild type and mutants were grown on one hundred TSA plates 783 
for 24 hours and harvested in saline. The cells were then inoculated into 10 L of Brucella 784 
broth, containing 7.5% heat inactivated horse serum and 25 mM sodium pyruvate to an 785 
OD600nm of approximately 0.05. After 24 hours of growth (OD600nm approximately 0.3), 786 
the bacteria were spun down at 4200 × g (Avanti J-25I, Beckman-Coulter) for 30 min and 787 
the pellets were lyophilized. Purification of CPS was performed by hot water/phenol 788 
extraction (Westphal and Jann, 1965). Briefly, 2 g of dry cell pellet were re-suspended in 789 
20 ml of MilliQ water pre-heated to 68°C. An equal amount of phenol (Fisher) preheated 790 
to 68°C was added to the pellet and sealed in a 50 ml conical tube. The samples were 791 
incubated at 68°C for 10 min with rapid stirring. They were allowed to cool to 10°C on 792 
ice and centrifuged for 30 min at 6300 × g (Eppendorf 5810R) and 10°C. The aqueous 793 
(top) phase was collected, and an equal amount of water was added to the remaining 794 
organic phase. The procedure was repeated three times and the aqueous phases were 795 
pooled. The aqueous phases were dialyzed (molecular weight cut off 12-14000 Da) 796 
against running water for 2-3 days until no phenol remained. The samples were 797 
lyophilized and re-suspended in double distilled water. Ultracentrifugation of the samples 798 
Page 35 of 74 Molecular Microbiology
For Peer Review
 
 36
for 30 hours at 4°C and 110000 × g (Optima Max-XP Ultracentrifuge, Beckman-Coulter) 799 
pelleted most of the LOS, while the CPS remained in the supernatant. The samples were 800 
lyophilized and re-suspended in 500 µl double distilled water. Treatment with 200 mg of 801 
Proteinase K was carried out for 2 hours at 60°C to degrade any remaining proteins. The 802 
CPS samples were stored at -20°C until further required. 803 
 804 
Sugar analysis 805 
 806 
CPS samples (0.2 mg each) were hydrolyzed with 2 M CF3CO2H (120 °C, 2 h), and the 807 
monosaccharides were identified using a Biotronik LC-2000 sugar analyzer (Germany) 808 
on a column (15 × 0.4 cm) of a Dionex A×8-11 anion-exchange resin and Ostion LC AN 809 
B cation-exchange resin (7.5 cm column each). Sugars were eluted with a stepwise 810 
gradient of 0.17 M (20 min) and 0.3 M sodium borate buffer pH 8.0 at 0.5 ml min
-1
 and 811 
detected with the bicinchoninate reagent.  812 
 813 
Nuclear magnetic resonance spectroscopy 814 
 815 
Samples were deuterium-exchanged by freeze-drying twice from 99.9% D2O and then 816 
examined as solutions in 99.95% D2O at 30° C on NMR spectra were recorded on an 817 
Avance II 600 spectrometer (Bruker, Germany) using internal sodium 3-818 
(trimethylsilyl)propanoate-2,2,3,3-d4 (δH 0, δC -1.6) or 85% H3PO4 (δP 0.0) as references 819 
for calibration. The 
1
H and 
13
C NMR spectra were assigned partially using two-820 
dimensional 
1
H,
1
H correlation spectroscopy (COSY), total correlation spectroscopy 821 
(TOCSY), rotating-frame nuclear Overhauser enhancement spectroscopy (ROESY), 822 
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1
H,
13
С heteronuclear single-quantum coherence (HSQC), and  
1
H,
31
P heteronuclear 823 
multiple-bond correlation (HMBC) experiments, which were performed using standard 824 
Bruker software. A mixing time of 100 ms was used in the TOCSY and ROESY 825 
experiments, and a 65-ms delay was used for evolution of long-range coupling in the 826 
1
H,
31
P HMBC experiment. TopSpin 2.1 (Bruker) program was used to acquire and 827 
process the NMR data.  828 
 829 
Growth curves assays 830 
 831 
A 100 ml sidearm flask containing 20 ml MH broth and background antibiotics (pre-832 
saturated with 85% N2, 10% CO2, and 5% O 2) was inoculated with C. jejuni cells grown 833 
on TSA at a starting OD600nm of 0.075. The flask was sealed and incubated with shaking 834 
(120 rpm) at 37˚C for up to 48 h. Growth was monitored over time using a Klett 835 
Summerson photocolimeter. 836 
 837 
Motility assays 838 
 839 
C. jejuni was harvested in MH broth and adjusted to OD600nm of 1.0 or 2.0. Motility plates 840 
(0.3% agar in MH) were stabbed in triplicate with the wild type or mutants and incubated 841 
for 24 h under microaerobic conditions at 37˚C. The diameter of the motility halo was 842 
monitored over time. 843 
 844 
Bile salts susceptibility assay 845 
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 846 
Following growth on TSA as described above, C. jejuni was harvested and washed once 847 
in saline and re-suspended in saline to an OD600nm of 0.1. Bile salts (50% cholate and 848 
50% deoxycholate, Sigma Aldrich) were diluted to the appropriate concentrations (0-2 849 
g/l) and 90 µl were aliquoted into the wells of a 96 well plate. Ten µl of the bacterial 850 
suspension were added to each well and incubated in microaerobic conditions at 37°C for 851 
15 minutes. The samples were washed once in TSB media and serially diluted for CFU 852 
counts. 853 
 854 
SDS susceptibility assays 855 
 856 
For SDS sensitivity assays, different concentrations (0.002 to 0.03%) of SDS were 857 
prepared in TSB (supplemented with vancomycin and trimethoprim). A volume of 170 858 
µL of each SDS concentration was added to the wells of a 96 well plate. C. jejuni wild 859 
type and mutants were grown as previously described and re-suspended in TSB to an 860 
OD600 nm 1.0. To each well, 30 µl of bacterial suspension was added, and control wells 861 
were set up which contained no SDS. The plates were incubated at 37˚C with shaking at 862 
180 rpm in microaerobic conditions for 15 h, at which point the OD600nm was read. The 863 
data were normalized to controls which did not receive any SDS treatment. 864 
 865 
Serum susceptibility 866 
 867 
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Fresh rabbit blood obtained from two rabbits was allowed to clot at room temperature. 868 
The serum was separated from the clot and centrifuged for 15 minutes at 10,000 rpm at 869 
4°C to remove remaining blood cells. Half of the serum was inactivated by incubation at 870 
56°C for 1 hr. Bacteria grown for 16-20 h on TSA were washed in saline and re-871 
suspended to an OD600nm of 0.1. Serum (inactivated or not) was re-suspended in saline to 872 
the appropriate concentration (0% - 100%) and 90 µl were aliquoted into the wells of a 96 873 
well plate. To the wells, 10 µl of bacteria were added. The plates were then incubated 874 
with shaking (100 rpm) for 1.5 h in microaerobic conditions at 37°C. Following 875 
incubation, 100 µl TSB was added to the wells and the samples were serially diluted and 876 
plated for CFU counts. For time course experiments, bacterial samples were exposed to 877 
20% pooled rabbit serum over 1.5 h. 878 
  879 
Phagocytosis and survival within macrophages 880 
 881 
RAW 267.4 murine macrophages (obtained from ATCC) were grown in Dulbeco’s 882 
Modified Eagles Medium (DMEM) containing 10% heat inactivated FBS, and passaged 883 
every 3-4 days to a maximum of 5 passages. Macrophages were seeded at ~2*10
5
 cells 884 
per well in 6-well plates, and incubated overnight in DMEM (containing 10% inactivated 885 
FBS). They were counted (final counts about 10
6
 per well after incubation) and C. jejuni 886 
bacteria that had been resuspended in tryptic soy (TS) broth and adjusted at the 887 
appropriate OD were added at a multiplicity of infection (MOI) of 1:100. After addition 888 
of the bacteria, the media composition was 97% (DMEM with 10% FBS) and 3% TS 889 
broth. The plates were centrifuged for 1 min at 300 x g to synchronize bacteria / 890 
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macrophage interaction. For adhesion experiments, the plates were incubated at 4°C for 891 
30 minutes to promote adhesion in the absence of phagocytosis (Peterson et al., 1977), 892 
washed with cold PBS five times and lysed in water. Control experiments showed that all 893 
strains resisted the water treatment (data not shown). The bacteria were then serially 894 
diluted and plated for CFU counts. For the time course of intracellular survival, the 895 
macrophages were exposed to the bacteria for 2 h at 37
o
C in a CO2 incubator. The cells 896 
were then washed three times with PBS and incubated with DMEM containing 225 µg/ml 897 
gentamicin for 1 h to kill extracellular bacteria. The macrophages were then washed and 898 
incubated in DMEM for up to 3 h. At each time point, the macrophages were washed 899 
three times with PBS and lysed in water (20 min). The samples were serially diluted and 900 
plated for CFU counts. For infection time course experiments, the macrophages were 901 
exposed to the bacteria for various lengths of time. The macrophages were washed in 902 
PBS, treated with gentamicin, and lysed in water, as described above. The surviving 903 
bacteria were enumerated by CFU counting. 904 
  905 
Adhesion and invasion of wild type and mutants to Caco-2 cells 906 
 907 
Caco-2 cells (obtained from ATCC) were grown for 3 days in DMEM containing 25 mM 908 
glucose and supplemented with 1.5 g/l sodium bicarbonate, 0.1 mM non-essential amino 909 
acids, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 µg/ml streptomycin until 910 
they formed a confluent monolayer (approximately 650,000 cells per well in 24-well 911 
plates) and were fully differentiated. The differentiation state of the cells was determined 912 
by measuring the hydrolysis of p-nitrophenyl phosphate in a standard colorimetric assay 913 
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(detection at 405 nm) which reflects the production of alkaline phosphatase and is a 914 
hallmark of differentiation (Ferruzza et al., 2012). The cells were infected for 5 h with C. 915 
jejuni at an MOI of 1:100. The bacteria were prepared as indicated for the macrophage 916 
experiments. The plates were centrifuged briefly (500 x g for 5 min at room temperature) 917 
to maximize contact between the bacteria and the cell monolayer. To determine total 918 
bacterial cell association (adhering and internalized bacteria), Caco-2 cell monolayers 919 
were washed 3 times, lysed with 0.1 % Triton X-100 for 10 min and CFUs were 920 
determined by plating serial dilutions. To determine the number of internalized bacteria, 921 
the infected monolayers were treated with 200 µg/ml gentamicin for 2 h to kill 922 
extracellular bacteria. The cells were then washed and treated as above to determine 923 
bacterial viable counts. 924 
 925 
Autoagglutination assay 926 
 927 
The autoagglutination assay was performed as previously described (Misawa and Blaser, 928 
2000). Briefly, 2 ml of sterile PBS were inoculated with C. jejuni at an OD600nm of 1.0. At 929 
time points 0, 1 and 2 h, the top 1 ml from each tube was carefully removed and the 930 
optical density was read at 600 nm. Live images were acquired using an Axioscope 2 931 
(Carl Zeiss) microscope with a 100× oil immersion objective coupled to a Qimaging 932 
(Burnaby) cooled charged-coupled device camera. 933 
 934 
Electron microscopy (EM) 935 
 936 
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EM was performed at the EM facility of the department of Microbiology and 937 
Immunology led by Dr. S. Koval with uranyl acetate staining as previously described 938 
(Merkx-Jacques et al., 2004).  939 
 940 
Chicken colonization assays 941 
 942 
Chicken colonization assays were performed as previously described (Vijayakumar et al., 943 
2006). C. jejuni was grown on TSA agar containing 5% sheep blood under microaerobic 944 
conditions at 42°C for 24 hours. The bacteria were re-suspended in PBS pH 7.4, and 945 
adjusted to an OD600nm of 0.35 (approx. 10E9 CFU/ml) and diluted 1:10 in PBS. Two-946 
day-old white-leghorn specific pathogen-free chicks were orally administered 100 µl 947 
(10E7 CFU) of either the C. jejuni wild type or one of the mutants. Five days later, the 948 
chicks were euthanized, the caeca and their contents were harvested, weighed and 949 
homogenized. Viable counts were obtained from s rial dilutions of samples that were 950 
plated on Campylobacter selective medium (CSM) plates (Quélab Inc., Montreal) for 48 951 
hours.  952 
 953 
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Table 1: Sugar and NMR spectroscopy analyses of hot water / phenol extracted CPS 1384 
from the wild type C. jejuni and its isogenic mutants.   1385 
Monosaccharide analysis was conducted with a sugar analyzer after full acid hydrolysis. 1386 
Numbers in the columns under “Sugar analysis data” represent the amounts of various 1387 
sugars present, after normalization to GalN. A plus (+) or minus (-) in the NMR 1388 
spectroscopy data columns represent either the presence or the absence of the specified 1389 
component, respectively. GalN = galactosamine (from GalNAc), Rib = ribose, Gal = 1390 
galactose (probably fr m the lipooligosaccharide), GlcA = glucuronic acid, Hep = 1391 
heptose, Me = methyl, MeOPN = O-methyl phosphoramidate, EtN = ethanolamine, GroN 1392 
= 2-amino-2-deoxyglycerol. 1393 
 1394 
 Sugar analysis 
data 
NMR spectroscopy data 
 GalN Rib Gal GlcA Hep 3,6-O-Me2 
on Hep 
MeOPN on 
GalNAc 
Substituent 
on GlcA 
Wild type 1 2.6 0.1 + + + - EtN 
wcaG::cat 1 1.2 trace + - -                                                                                                                             + EtN, GroN
mlghC::cat 1 3.6 0.15 + - -  trace                                                                    EtN, GroN
mlghB::cat 1 1.4 0.18 + -                                                                                                                             - + EtN, GroN
wcaG::cat∆ 1 0.9 trace + - - - EtN, GroN 
kpsM::kan 1 2.7 trace Not analyzed 
 1395 
1396 
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Table 2: 
1
H and 
13
C NMR data for the CPS isolated from C. jejuni wild type and 1397 
isogenic mutants wcaG::cat, mlghB::cat, mlghC::cat and wcaG::cat∆. 1398 
a
: Data from this study. 1399 
b
: The mutant mlghC::cat had essentially the same chemical shifts.                                                                                                                                                                  1400 
c
: The mutant wcaG::cat had essentially the same chemical shifts.                                                                                                                                         1401 
d
: Published data (McNally et al., 2007). 1402 
e
: Values without/with the MeOPN modification at position 3. 1403 
 1404 
Sugar 
residue 
Atom 
or 
position 
Type Chemical 
shift 
(ppm) 
Wild 
type
a
 
Mutants NCTC 
11168H
d
 wcaG::cat∆
 
a,b
 
mlghB::cat
 
a,c
 
Rib 1 CH δH 5.36 5.38 5.38 5.36 
δC 106.3 105.9 106.0 106.1 
GalNAc 1 CH δH 4.97 4.98 5.03 5.08/5.02
e
 
δC 106.1 106.7         106.9  105.1/104.3
e
 
3 CH δH 4.25 4.17 4.76 4.93/4.23
e
 
δC 75.4    76.8 81.0 78.8/73.9
e
 
3 MeOPN δH none none 3.77 3.77 
δC none none 55.0 54.6 
δP none none 13.6 not 
indicated 
GlcA 1 CH δH 5.14 5.22  5.22 5.12 
   δC 99.0 99.0 99.0 98.8 
Hep 1 CH δH 5.58 none none 5.58 
δC 98.3 none none 97.9 
3 MeO δH 3.63 none none 3.61 
δC 60.8 none none 60.7 
6 MeO δH 3.56 none none 3.55 
δC 60.8 none none 59.3 
 1405 
 1406 
1407 
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Table 3. Comparison of motility for wild type and mutant strains. 1408 
The motility of the wild type and mutant strains were measured and compared 1409 
quantitatively after stabbing into 0.3% agar and incubation for 48 hours under 1410 
microaerobic conditions. The values shown are for the diameters of the motility halos, 1411 
measured in centimeters. The mean and standard errors (SE) of three independent 1412 
experiments are shown for each strain. In addition, the p value, as determined by one-way 1413 
ANOVA, is shown. Compared to the wild type, all mutant strains were significantly 1414 
reduced in motility. 1415 
 1416 
C. jejuni strain Diameter of halo (cm) ± SE p value 
wild type 3.09 ± 0.09 N/A 
wcaG::cat 2.35 ± 0.08 < 0.01 
mlghC::cat 2.77 ± 0.06 < 0.01 
mlghB::cat 2.73 ± 0.06 < 0.01 
wcaG::cat∆ 2.38 ± 0.10 < 0.01 
kpsM::kan 0.00 ± 0.00 < 0.01 
 1417 
 1418 
1419 
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Table 4: List of primers used to construct mutants and perform qRT-PCR analyses. 1420 
When applicable, the restriction sites are indicated in bold letters. 1421 
 1422 
Primer name Sequence (5’ – 3’) 
Aph3 P1  GAAGATCTGATAAACCCAGCGAACCA 
Aph3 P2  AGGGTCCATGGAGACATCTAAATCTAGGTAC 
CatColi P2  GTCGGTACCTTATTTATTCAGCAAGTCTTG 
CatColi P3  GTCATCGGGCCCTTCCTTTCCAAGTTAATTGC 
cj1427c P2  AGGGTCCATGGGCATGTCAAAAAAAGTTTTAATTAC 
cj1427c P3  GCGTCGGATCCTTAATTAAAATTTGCAAAGCGA 
cj1427c P4  GTGGGTACCTAGAATGAGACTTGA 
cj1427c P5  CTGCTAGGGCCCATATTCTGAGATAGG 
cj1428c P2  AGGTACCATGGGCATGCAAACAAATTCAAAAATATAA 
cj1428c P3 GCTGGATCCTCAATTTTGTGTTTTATACCA 
cj1428c P4 GTGGGTACCTGTAGCTATCTATACGATGC 
cj1428c P5 CTGCTAGGGCCCCTCAGGATACATATACCCA 
cj1430c P2  AGGGTCCATGGCAATAGAATTTGATATA 
cj1430c P3  GCGTCGGATCCTTATCCTTTATTTTTAGTTGCAA 
cj1430c P4  GTGGGTACCAAATATGGGAAATTCT 
cj1430c P5  CTGCTAGGGCCCATTTTAAATAGGTTGG 
kpsM P2  AGGTACCATGGTGAGTTATGATTATAGTTTATG 
kpsM P3  GCTGGATCCTAGATTAATTAACTTTATCATTC 
kpsM P4  GAAGATCTTGTATTTCCTGTTCATTTGC 
kpsM P6  AGGTACCATGGAGTTCTAGCAATAAATACATG 
RT1425F  ACCACTTGGTACATCCGAATAGGT 
RT1425R TGCGACTATATCTTTATACATACATTG 
RT1426F TTATCGACATAAAGCATCTTGTAAAAAA 
RT1426R ATTGATAATCATCAGCAAGCTAGGAA 
RT1427F CCGCATGCACTTTATCGATCCCA 
RT1427R CTGATATTATTATTCCTCTAGCTGCT 
RT1428F AAATCACCTTGAAATAAATATTCCTCTT 
RT1428R CAAGCGGTTGCTAAATTTTTTAAAGAA 
RT1430F TTTTATAACTTATAATAAATTTCTCCCATT 
RT1430R ATTTGGACAGCTTTTACAGATGAATAT 
RT1444F TGAATCCGAACTAAGTCCTTGATAAA 
RT1444R AGTGGTGGATTCTCAAGGAAATATTT 
RT1445F AAGGTAAATCTATATGTTGCTCTTGAT 
RT1445R ATACATTGATTGCAGCACCAAGATAT 
RT1447F CCTTTATTTAGTGGTGGAAGACATTA 
RT1447R TTATCTCTAGCTGTTAAAGAACCTTG 
RTKpsMF ATTACAAAATAAATACAAAACTCAAGTAAA 
RTKpsMR GTTAGAGAATATCATCATCAAGTTATG 
RTAcCoAF AATGTCTTGATCGTCATATGAAAACAA 
RTAcCoAR TAGCCCCAATCCTTGCACAAGCT 
1423 
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FIGURE LEGENDS: 1424 
Fig. 1: Schematic representation of the CPS from C. jejuni ATCC 700819 and 1425 
organization of its CPS gene cluster. Panel A: The CPS unit comprises 4 sugars, 1426 
including a 3-sugar linear backbone (sugars 1-3) that is attached to a phospholipid (PL) 1427 
for anchorage in the membrane and a modified heptose (H) branch. The exact structure is 1428 
also indicated and denotes additional modifications such as O-methyl phosphoramidate 1429 
(MeOPN on GalNAc and heptose) and addition of ethanolamine (EtN) or 2-amino-2-1430 
deoxyglycerol (GroN) on GlcA (Karlyshev et al., 2005; McNally et al., 2007; St Michael 1431 
et al., 2002). Panel B: Global organization of the CPS gene cluster (Karlyshev et al., 1432 
2005; Parkhill et al., 2000) showing the tripartite organization of CPS genes as well as 1433 
the genes relevant to this study. Diagram not to scale. 1434 
  1435 
Fig. 2: Simplified biochemical pathway highlighting the role of enzymes encoded by 1436 
wcaG, mlghB and mlghC in the synthesis of L-gluco-heptose. Intricacies of this 1437 
pathway were described earlier (McCallum et al., 2011; McCallum et al., 2012; 1438 
McCallum et al., 2013). This figure only highlights the lin ar pathway from the manno-1439 
heptose precursor to the final product (additional intermediates excluded) as well as the 1440 
side branch mediated by WcaG that decreases product formation via substrate 1441 
scavenging. R represents OH or OMe. It is not known when methylation by cj1426c 1442 
occurs along this pathway (as denoted by ?).  1443 
 1444 
Fig. 3: SDS-PAGE analysis of the CPS produced by wild type and mutants. Panel A: 1445 
CPS extracted by hot water/phenol method was analyzed on a 13 cm long gel with 1446 
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detection by silver staining. Panel B: CPS obtained by SDS solubilization of total cells 1447 
and proteinase K digestion of all proteins was analysed on a 5 cm gel. Detection was 1448 
performed with anti-HS:2 Penner serotyping antibody (kindly supplied by Dr M. 1449 
Karmali). The wcaG::cat mutant is not represented on panel B as no antibody was 1450 
available anymore when the proper mutant was obtained. 1451 
 1452 
Fig. 4: CPS structures of the wild type strain and the mutants. The structures are 1453 
based on the data presented in Tables 1 and 2 and in supplementary Figures S1 and S2, 1454 
and also take into account previously published data for the wild type strain (McNally et 1455 
al., 2007; St Michael et al., 2002; Szymanski et al., 2003). 1456 
 1457 
Fig. 5: qRT-PCR analysis of expression of capsular genes in the wild type and 1458 
mutants. Panel A: Intra-strain comparison where the level of transcription of each gene 1459 
is expressed relatively to housekeeping gene acetyl-CoA synthase in the same strain. 1460 
Panel B: Inter-strain comparison where data from panel A are expressed relatively to 1461 
wild type (Pfaffl, 2001). Cat and Kan denote the antibiotic resistance cassettes used for 1462 
gene inactivation. Crosses for wcaG::cat∆ denote deleted genes. Additional genes deleted 1463 
in this mutant are not shown as their levels of transcription were not investigated. Small 1464 
arrows indicate promoters inferred from differential transcription of neighboring genes in 1465 
each individual data set. The +/- refers to standard error obtained from 2 independent 1466 
experiments each including triplicate. Darker and darker shades indicate more and more 1467 
deviation from housekeeping levels (Panel A) or from wild type levels (Panel B), red 1468 
being for reduced levels and green for higher levels. ND: none detected. NA: not 1469 
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applicable, used for kpsM in wcaG::cat∆ and mlghC::cat where data could not be 1470 
calculated since levels were too low in the wild type reference but colors nevertheless 1471 
indicate higher transcription than in wild type in both strains, with a 10-fold difference 1472 
between wcaG::cat∆ and mlghC::cat as per Panel A. 1473 
 1474 
Fig. 6: Effect of mutations on growth rates, auto-agglutination and flagellum 1475 
production. Panel A: Growth curves in broth under microaerobic atmosphere 1476 
determined using Klett’s flasks over 24 h. Error bars represent SEM (standard error of the 1477 
mean) for 3 independent experiments with 1 reading/flask at each time point. Panel B: 1478 
Auto-agglutination quantitated by measuring the OD600nm of the top layer of a static 1479 
bacterial suspension over time. Error bars represent SEM for 3 independent experiments 1480 
each including 3 replicates. The same color scheme applies as in panel A. *: p<0.01 by 1481 
one-way ANOVA (with Dunnett’s post test). Panel C: Phase contrast microscopic 1482 
examination of auto-agglutination for kpsM::kan compared with wild type (100x 1483 
magnification). Panel D: Electron microscopy analysis of flagella production in wild 1484 
type and kpsM::kan strains with uranyl acetate staining. 1485 
 1486 
Fig. 7: Effect of mutations on resistance to bile salts and SDS. Panel A: Resistance to 1487 
various concentrations of bile salts. The bacteria were exposed to bile for 15 min under 1488 
microaerobic atmosphere at 37
o
C and serially diluted for enumeration of viable cells by 1489 
CFU counting. Panel B: Resistance to various concentrations of SDS. The cells were 1490 
exposed to SDS for 15 h and cell lysis was assessed by measuring the OD600nm. The 1491 
legend is the same in both panels and is shown within panel B. Error bars represent SEM 1492 
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for three independent experiments, each carried out with triplicates. Data for each replica 1493 
were obtained from 2 CFU spots Panel A and 1 OD600nm read for Panel B. 1494 
 1495 
Fig. 8: Effect of mutations on resistance to serum. Panel A: Resistance to various 1496 
concentrations of serum for 1.5 h under microaerobic atmosphere at 37
o
C. Panel B: Time 1497 
course of resistance to 20% serum. For both panels, viability was assessed by CFU 1498 
counting. The legend is the same in both panels and is shown within panel A. Error bars 1499 
represent SEM. Experiments performed 3 times independently with triplicates within 1500 
each experiment and determination of CFU from 2 spots for each replica. 1501 
 1502 
Fig. 9: Effect of mutations on interactions with epithelial cells. The bacteria were 1503 
centrifuged onto cell monolayers to account for motility defects. Panel A: Adherence to 1504 
Caco-2 cells measured after 5h incubation, with elimination of unbound bacteria by 1505 
washing and CFU counting of bound bacteria. Panel B: Invasion of Caco-2 cells 1506 
measured after 5 h incubation and after elimination of externally bound bacteria via 1507 
gentamicin treatment.  Live intracellular bacteria were enumerated via CFU counting 1508 
after lysis of epithelial cells with Triton X-100. ND: none detected. Error bars represent 1509 
SEM. *: p<0.05. **: p<0.01 by one-way ANOVA. Experiments performed 3 times with 1510 
duplicates within each experiment and determinations from 2 CFU spots for each replica. 1511 
 1512 
Fig. 10: Effect of the mutations on colonization and persistence in chicken intestine. 1513 
Two day old chicks were orally gavaged with 10
7
 CFU and their caecal content in C. 1514 
jejuni was determined after 5 days by CFU counting of plated caecal homogenate. Panel 1515 
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A: Test of wild type and four mutants. Panel B: Test of wild type and one additional 1516 
mutant. While experiments were performed following the same procedure, a slightly 1517 
lower level of colonization and wider distribution of colonization levels were obtained for 1518 
wild type in panel B compared with panel A, therefore, the data for the last mutant tested 1519 
are displayed separately. For both panels, each data point represents an individual chick. 1520 
The numbers at the top of the graphs are the number of chicks from which C. jejuni was 1521 
isolated over the total number of chicks inoculated for each strain tested. The lower limit 1522 
of detection for colonization was ~ 1.5 log CFU/g. Horizontal bars represent the median 1523 
of each group. Significant differences (**** p< 0.0001; *** p<0.001; ** p<0.01; * p< 1524 
0.05) in colonization compared to wild type as determined by the Mann-Whitney test are 1525 
indicated. A second experiment was performed with an inoculation dose of 10
6
 and 1526 
similar data were obtained (data not shown).  1527 
 1528 
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Graphical abstract for Wong et al 2015 
 
80 words. 
 
Campylobacter jejuni ATCC 700819 produces a capsule that is important for virulence and contains a 
modified heptose. Inactivation of any of the genes wcaG, mlghB, and mlghC involved in heptose 
modification leads to capsule lacking modified heptose and presenting altered MeOPN, EtN and NGro 
contents. This alters capsule barrier functions and interactions with intestinal cells and decreases 
colonization and/or persistence in the chicken gut. This demonstrates that these genes contribute to 
bacterial resistance against host defenses in the gastrointestinal tract. 
 
Legend for figure: 
Chicken caecum colonization by heptose modification mutants and schematic representation of their 
capsule composition. 
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